SGS Launches GMP-Compliant NMR Testing for the Pharmaceutical Industry in China
SGS expands GMP analytical capabilities in China with the launch of NMR testing for pharmaceutical development and manufacturing.
BAAR, SWITZERLAND, June 3, 2026 /EINPresswire.com/ – SGS, the world’s leading testing, inspection and certification company, has expanded its analytical capabilities for the Chinese pharmaceutical industry with the introduction of nuclear magnetic resonance (NMR) testing.
This new service offers robust qualitative and quantitative analysis for both drug substances and drug products, ensuring the highest standards of identity, purity and quality throughout drug development and manufacturing.
NMR is a non-destructive analytical technique that reveals detailed molecular structures and compositions. It complements existing chromatographic and spectroscopic methods, enabling: • Active pharmaceutical ingredient (API) structure confirmation and isomer differentiation • Impurity and degradation product identification down to 0.1% w/w • Polymorphism analysis to support solid-form control • Quantitative NMR (qNMR) for accurate, traceable assay results
The new NMR service offers cost-effective, high-throughput analysis, making it ideal for routine quality control, identity testing, purity assessment and quantitation of synthesized drug substances and raw materials.
This expansion reinforces SGS’s commitment to providing innovative, compliant and high-value testing solutions, supporting pharmaceutical manufacturers across China in ensuring product safety, efficacy and regulatory confidence.
Stakeholders are advised to download SGS’s technical brochure for more information.
Mrs Ruth Roy Sugarloaf Marketing +44 7933 563883
Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.
Sign up for:
Consumer Products Asia
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.